1887

Abstract

SARS-CoV-2 is the cause of the still-ongoing COVID-19 pandemic. To date reports on re-infections after full recovery from a previous COVID-19 course remain limited due to the fact that re-infections or second infections occur at the earliest between 3 to 24 months after full recovery while the pandemic lasts only since a year. Even less data are available on re-infections associated with emerging variants.

A 33-year-old previously healthy male patient was tested twice SARS-CoV-2 RNA positive with an 8 months symptom-free interval between the two COVID-19 episodes in our setting in Cologne, Germany. While the first episode was accompanied by a co-detection of human bocavirus and hardly any symptoms, the second episode was characterized by serious illness and severe flu-like symptoms, although hospitalization was not required. After the first episode no residual viral RNA was detected after the patient was released from quarantine. Follow up of the patient revealed a moderate but significant reduction of the lung volume and slightly impaired diffusion capacity.

While it is known that re-infections with SARS-CoV-2 may occur this is the first report of a co-detection of human bocavirus (HBoV) during a primary SARS-CoV-2 infection. The first, hardly symptomatic episode showed that co-infections do not necessarily initiate severe COVID-19 courses. The second more severe episode with serious flu-like symptoms could be explained by the sustained mild damage of the airways during the primary infection.

Keyword(s): HBoV , re-infection and SARS-CoV-2
  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. The Microbiology Society waived the open access fees for this article.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000339
2022-04-06
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/acmi/4/4/acmi000339.html?itemId=/content/journal/acmi/10.1099/acmi.0.000339&mimeType=html&fmt=ahah

References

  1. Windisch W, Pieper M, Ziemele I, Rockstroh J, Brockmann M et al. Latent infection of human bocavirus accompanied by flare of chronic cough, fatigue and episodes of viral replication in an immunocompetent adult patient, Cologne, Germany. JMM Case Rep 2016; 3:e005052 [View Article] [PubMed]
    [Google Scholar]
  2. To KK, Hung IF, Ip JD, Chu AW, Chan WM et al. COVID-19 re-infection by a phylogenetically distinct sarssars-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis 2020; 73:e2946-e2951 [View Article]
    [Google Scholar]
  3. Ozaras R, Ozdogru I, Yilmaz AA. Coronavirus disease 2019 re-infection: first report from Turkey. New Microbes New Infect 2020; 38:100774 [View Article] [PubMed]
    [Google Scholar]
  4. Larson D, Brodniak SL, Voegtly LJ, Cer RZ, Glang LA et al. A case of early re-infection with severe acute respiratory syndrome coronavirus 2 (SARS-cov-2). Clin Infect Dis 2020; 73:e2827-e2828
    [Google Scholar]
  5. Kim AY, Gandhi RT. Reinfection with severe acute respiratory syndrome coronavirus 2: what goes around may come back around. Clin Infect Dis 2020; 73:e3009-e3012
    [Google Scholar]
  6. Kang H, Wang Y, Tong Z, Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection?. J Med Virol 2020; 92:2263–2265 [View Article] [PubMed]
    [Google Scholar]
  7. Colson P, Finaud M, Levy N, Lagier JC, Raoult D. Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect 2021; 82:84–123 [View Article] [PubMed]
    [Google Scholar]
  8. Bongiovanni M, Basile F. Re-infection by COVID-19: a real threat for the future management of pandemia?. Infect Dis (Lond) 2020; 52:581–582 [View Article] [PubMed]
    [Google Scholar]
  9. AlFehaidi A, Ahmad SA, Hamed E. SARS-CoV-2 re-infection: a case report from Qatar. J Infect 2021; 82:414–451 [View Article] [PubMed]
    [Google Scholar]
  10. Schildgen V, Demuth S, Lüsebrink J, Schildgen O. Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based Perspective. Pathogens 2021; 10:38 [View Article] [PubMed]
    [Google Scholar]
  11. Schildgen V, Lüsebrink J, Thomaidis P, Meibert P, Schildgen O. Diagnostic stumbling blocks in the COVID-19 monitoring of medical staff while putting hygiene requirements into practice. New Microbes New Infect 2020; 37:100735 [View Article] [PubMed]
    [Google Scholar]
  12. Höpken M, Förster I, Maune S, Brockmann M, Schildgen O et al. Association of the Human Bocavirus With Tonsil Squamous Cell Carcinomas. Front Microbiol 2018; 9:2450 [View Article] [PubMed]
    [Google Scholar]
  13. Schildgen V, Malecki M, Tillmann RL, Brockmann M, Schildgen O. The Human Bocavirus Is Associated with Some Lung and Colorectal Cancers and Persists in Solid Tumors. PLoS One 2013; 8:e68020 [View Article] [PubMed]
    [Google Scholar]
  14. Wu X, Cai Y, Huang X, Yu X, Zhao L et al. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China. Emerg Infect Dis 2020; 26:1324–1326 [View Article] [PubMed]
    [Google Scholar]
  15. Cuadrado-Payán E, Montagud-Marrahi E, Torres-Elorza M, Bodro M, Blasco M et al. SARS-CoV-2 and influenza virus co-infection. Lancet 2020; 395:e84 [View Article] [PubMed]
    [Google Scholar]
  16. Tadolini M, García-García J-M, Blanc F-X, Borisov S, Goletti D et al. On tuberculosis and COVID-19 co-infection. Eur Respir J 2020; 56:2002328 [View Article] [PubMed]
    [Google Scholar]
  17. Touzard-Romo F, Tapé C, Lonks JR. Co-infection with SARS-CoV-2 and Human Metapneumovirus. R I Med J (2013) 2020; 103:75–76 [PubMed]
    [Google Scholar]
  18. Oliva A, Siccardi G, Migliarini A, Cancelli F, Carnevalini M et al. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection 2020; 48:871–877 [View Article] [PubMed]
    [Google Scholar]
  19. Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi HAA et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life 2020; 72:2097–2111 [View Article] [PubMed]
    [Google Scholar]
  20. Langford BJ, So M, Raybardhan S, Leung V, Westwood D et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020; 26:1622–1629 [View Article] [PubMed]
    [Google Scholar]
  21. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K et al. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing. Clin Infect Dis 2020; 71:2459–2468 [View Article] [PubMed]
    [Google Scholar]
  22. Peltola V, Söderlund-Venermo M, Jartti T. Human bocavirus infections. Pediatr Infect Dis J 2013; 32:178–179 [View Article] [PubMed]
    [Google Scholar]
  23. Nora-Krukle Z, Vilmane A, Xu M, Rasa S, Ziemele I et al. Human Bocavirus Infection Markers in Peripheral Blood and Stool Samples of Children with Acute Gastroenteritis. Viruses 2018; 10:E639 [View Article] [PubMed]
    [Google Scholar]
  24. Dagan N, Barda N, Kepten E, Miron O, Perchik S et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med 2021; 384:1412–1423 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000339
Loading
/content/journal/acmi/10.1099/acmi.0.000339
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error